UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 186

Sortiert nach

MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure

Investigational new drugs, 2009-08, Vol.27 (4), p.379-386

2009

Volltextzugriff (PDF)

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial

Journal of clinical oncology, 1998-04, Vol.16 (4), p.1574-1581

1998

Volltextzugriff (PDF)

Dose-Dependent Effects of Selenized Yeast on Total Selenium Levels in Prostatic Tissue of Men With Prostate Cancer

Nutrition and cancer, 2011-01, Vol.63 (1), p.1-5

2011

Volltextzugriff (PDF)

Comparison of Prostate Specific Antigen Concentration Versus Prostate Specific Antigen Density in the Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves

The Journal of urology, 1994-12, Vol.152 (6), p.2031-2036

1994

Volltextzugriff (PDF)

Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study

Anti-cancer drugs, 2003-09, Vol.14 (8), p.589-594

2003

Volltextzugriff (PDF)

Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the ‘Watchful Waiting’ Study

Anti-cancer drugs, 2003-09, Vol.14 (8), p.595-600

2003

Volltextzugriff (PDF)

Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves

The Journal of urology, 1994-12, Vol.152 (6), p.2037-2042

1994

Volltextzugriff (PDF)

Prostate Specific Antigen Levels in Men Older than 50 Years without Clinical Evidence of Prostatic Carcinoma

The Journal of urology, 1993-12, Vol.150 (6), p.1837-1839

1993

Volltextzugriff (PDF)

Randomized Study of Neoadjuvant Testicular Androgen Ablation Therapy Before Radical Prostatectomy in Men with Clinically Localized Prostate Cancer

The Journal of urology, 1996-04, Vol.155 (4), p.1357-1360

1996

Volltextzugriff (PDF)

The Clinical Usefulness of Serum Prostate Specific Antigen After Hormonal Therapy of Metastatic Prostate Cancer

The Journal of urology, 1992-03, Vol.147 (3), p.956-961

1992

Volltextzugriff (PDF)

Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men

The Journal of urology, 1994-05, Vol.151 (5), p.1283-1290

1994

Volltextzugriff (PDF)

Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity

Internal medicine journal, 2012-04, Vol.42 (4), p.374-380

2012

Volltextzugriff (PDF)

A reassessment of the clinical implications of the superior vena caval syndrome

Journal of clinical oncology, 1984-08, Vol.2 (8), p.961-969

Ahmann, F R

1984

Volltextzugriff (PDF)

Tin-117m(4+)DTPA: Pharmacokinetics and Imaging Characteristics in Patients with Metastatic Bone Pain

The Journal of nuclear medicine (1978), 1997-02, Vol.38 (2), p.230-237

1997

Volltextzugriff (PDF)

ATP Assay: Ability To Distinguish Cytostatic From Cytocidal Anticancer Drug Effects

JNCI : Journal of the National Cancer Institute, 1986-11, Vol.77 (5), p.1039-1045

1986

Volltextzugriff (PDF)

Prospective Longitudinal Evaluation of Men With Initial Prostate Specific Antigen Levels of 4.0 Ng./Ml. or Less

The Journal of urology, 1997-05, Vol.157 (5), p.1740-1743

1997

Volltextzugriff (PDF)

Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared

Clinical chemistry (Baltimore, Md.), 1987-11, Vol.33 (11), p.2086

1987

Volltextzugriff (PDF)

Ketoconazole-induced adrenal crisis in a patient with metastatic prostatic adenocarcinoma: Case report and review of the literature

Urology (Ridgewood, N.J.), 1997-05, Vol.49 (5), p.781-785

1997

Volltextzugriff (PDF)

Prospective Comparison between Serum Monoclonal Prostate Specific Antigen and Acid Phosphatase Measurements in Metastatic Prostatic Cancer

The Journal of urology, 1987-03, Vol.137 (3), p.431-434

1987

Volltextzugriff (PDF)

Treatment of castration-induced menopausal symptoms with low dose diethylstilbestrol in men with advanced prostate cancer

Urology (Ridgewood, N.J.), 1992-12, Vol.40 (6), p.499-502

1992

Volltextzugriff (PDF)

Cytokeratin characterization of human prostatic carcinoma and its derived cell lines

Cancer research (Chicago, Ill.), 1987, Vol.47 (1), p.281-286

1987

Volltextzugriff (PDF)

The effect of digital rectal examination on serum levels of prostatic-specific antigen

Archives of pathology & laboratory medicine (1976), 1988-11, Vol.112 (11), p.1110

1988

Volltextzugriff (PDF)

No Effect of Selenium Supplementation on Serum Glucose Levels in Men with Prostate Cancer

The American journal of medicine, 2010-08, Vol.123 (8), p.765-768

2010

Volltextzugriff (PDF)

Leukoerythroblastic anemia in metastatic prostate cancer. Clinical and prognostic significance in patients with hormone‐refractory disease

Cancer, 1993-06, Vol.71 (11), p.3594-3600

1993

Volltextzugriff (PDF)

Comparative evaluation of serum CA 195 and carcinoembryonic antigen in metastatic carcinoma

Cancer, 1993-06, Vol.71 (11), p.3625-3632

1993

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(186)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(15)
Diabetes Care
(12)
Cancer
(11)
Journal Of Clinical Oncology
(10)
Cancer Research
(9)
Cancer Treatment Reports
(8)
Arizona Medicine
(7)
Blood
(7)
Investigational New Drugs
(6)
American Journal Of Clinical Oncology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial

Dose-Dependent Effects of Selenized Yeast on Total Selenium Levels in Prostatic Tissue of Men With Prostate Cancer

Comparison of Prostate Specific Antigen Concentration Versus Prostate Specific Antigen Density in the Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves

Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study

Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the ‘Watchful Waiting’ Study

Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves

Prostate Specific Antigen Levels in Men Older than 50 Years without Clinical Evidence of Prostatic Carcinoma

Randomized Study of Neoadjuvant Testicular Androgen Ablation Therapy Before Radical Prostatectomy in Men with Clinically Localized Prostate Cancer

The Clinical Usefulness of Serum Prostate Specific Antigen After Hormonal Therapy of Metastatic Prostate Cancer

Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men

Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity

A reassessment of the clinical implications of the superior vena caval syndrome

Tin-117m(4+)DTPA: Pharmacokinetics and Imaging Characteristics in Patients with Metastatic Bone Pain

ATP Assay: Ability To Distinguish Cytostatic From Cytocidal Anticancer Drug Effects

Prospective Longitudinal Evaluation of Men With Initial Prostate Specific Antigen Levels of 4.0 Ng./Ml. or Less

Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared

Ketoconazole-induced adrenal crisis in a patient with metastatic prostatic adenocarcinoma: Case report and review of the literature

Prospective Comparison between Serum Monoclonal Prostate Specific Antigen and Acid Phosphatase Measurements in Metastatic Prostatic Cancer

Treatment of castration-induced menopausal symptoms with low dose diethylstilbestrol in men with advanced prostate cancer

Cytokeratin characterization of human prostatic carcinoma and its derived cell lines

The effect of digital rectal examination on serum levels of prostatic-specific antigen

No Effect of Selenium Supplementation on Serum Glucose Levels in Men with Prostate Cancer

Leukoerythroblastic anemia in metastatic prostate cancer. Clinical and prognostic significance in patients with hormone‐refractory disease

Comparative evaluation of serum CA 195 and carcinoembryonic antigen in metastatic carcinoma

Suchergebnisse filtern